In congestive heart failure (CHF), increased sympathetic drive and reduced renal perfusion activate the peripheral renin-angiotensin-aldosterone-system (RAAS). The resulting peripheral vasoconstriction and sodium and water retention by the kidneys precipitate further clinical deterioration by increasing the stress on the already failing ventricle. These peripheral effects of RAAS activation have been the targets of successful therapeutic interventions (afterload reduction and volume control) in heart failure. Nevertheless, the clinical course of heart failure is progressive, the long-term prognosis remains dismal, and the search for innovative approaches to therapy continues. Angiotensin II (ANGII) has prominent central nervous system (CNS) effects on fluid balance and sympathetic drive that have been well studied in the context of hypertension, but have been largely overlooked in heart failure. The hypothesis of the proposed studies is that the CNS effects of high circulating ANGII contribute substantially to the augmented sympathetic drive and fluid accumulation that characterize the late stage of established heart failure. Secondary hypotheses are that these CNS effects of ANGII are exacerbated by high aldosterone levels, and opposed by high levels of atrial natriuretic peptide (ANP), secreted by the failing heart. The model to be studied is left ventricular dysfunction caused by proximal occlusion of a coronary artery in the rat, simulating the most common cause of heart failure in humans. Extent of left ventricular dysfunction will be determined by echocardiography and confirmed anatomically.
The specific aims are to determine whether, in rats with CHF: 1) forebrain mechanisms activated by high levels of circulating neuropeptides contribute to augmented neurohumoral drive, 2) blood-borne neuropeptides acting on forebrain circumventricular organs alter the balance of excitatory and inhibitory neurotransmitter systems in the paraventricular nucleus of the hypothalamus to favor neurohumoral excitation. This work will provide new information concerning the role of the central nervous system in the pathophysiology of CHF and will draw attention to the possibility of CNS directed drug therapy for heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063915-02
Application #
6476905
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Reinlib, Leslie
Project Start
2000-12-20
Project End
2005-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
2
Fiscal Year
2002
Total Cost
$330,750
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Felder, Robert B (2010) Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp Physiol 95:19-25
Wei, Shun-Guang; Zhang, Zhi-Hua; Yu, Yang et al. (2009) Systemically administered tempol reduces neuronal activity in paraventricular nucleus of hypothalamus and rostral ventrolateral medulla in rats. J Hypertens 27:543-50
Tobaldini, Eleonora; Montano, Nicola; Wei, Shun-Guang et al. (2009) Autonomic cardiovascular modulation. IEEE Eng Med Biol Mag 28:79-85
Tobaldini, Eleonora; Porta, Alberto; Wei, Shun-Guang et al. (2009) Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure rats. Auton Neurosci 150:21-6
Felder, R B; Yu, Y; Zhang, Z-H et al. (2009) Pharmacological treatment for heart failure: a view from the brain. Clin Pharmacol Ther 86:216-20
Grippo, Angela J; Johnson, Alan Kim (2009) Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 12:1-21
Yu, Yang; Kang, Yu-Ming; Zhang, Zhi-Hua et al. (2007) Increased cyclooxygenase-2 expression in hypothalamic paraventricular nucleus in rats with heart failure: role of nuclear factor kappaB. Hypertension 49:511-8
Kang, Yu-Ming; Zhang, Zhi-Hua; Johnson, Ralph F et al. (2006) Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res 99:758-66
Zhang, Zhi-Hua; Kang, Yu-Ming; Yu, Yang et al. (2006) 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 48:127-33
Francis, Joseph; Chu, Yi; Johnson, Alan Kim et al. (2004) Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol 286:H2264-71

Showing the most recent 10 out of 21 publications